Vita Life Sciences' (ASX:VLS) shareholders approved an on-market share buyback of up to 15% of the share capital of the firm at the annual general meeting on May 28, according to a Monday Australian bourse filing.
It currently has 54.2 million total shares on issue.
It will evaluate market conditions and the share price, as it plans to continue to buy back shares in the year ahead.
Shares rose 2% in recent trading on Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.